Latest News Archive
Please select Category, Year, and then Month to display items
18 September 2018
Photo Hanno Otto
The OSM Camerata is once again a winner, sharing the first prize in the Ictus International Music Competition with the Oklahoma State University.
If Einstein’s string theory had a musical undertone, one would think it is because of the sweet melodies of the Odeion School of Music Cameratas’ (OSMC) violins and cellos. It should therefore come as no surprise that OSMC won the 2018 International Ictus Music Competition, again. The ensemble has been paving the way to numerous successes since its inception in 2012.
This year, however, the OSMC is sharing the first prize with the Oklahoma State University Symphony Orchestra, under the direction of Dr Thomas Dickey. The OSMC’s competition recital for 2018 was conducted by principle conductor, Xavier Cloete. Acclaimed violist Elsabé Raath, joined the OSMC artistic team in 2017 as string clinician.
OSMC the jewel in crown
The OSMC is based at the Odeion School of Music (OSM) at the University of the Free State UFS) and was strategically founded as the OSM’s flagship ensemble with the main objective, creating a catalyst for excellence. “From a pedagogical perspective, it serves as a feasible incubator to nurture fully-rounded musicians who are thoroughly prepared for the demands of their trade as orchestral musicians, soloists and conductors,” said Marius Coetzee founder of the OSMC.
“Ms Raath also made her debut as conductor during the 2018 Ictus Music Competition where she conducted O Sacrum Convivium by Olivier Messiaen,” said Coetzee, founder of the OSMC. Elsabé was also conductor during the 2018 Ictus Music competition.
The OSMC’s concert programme for Ictus 2018 also consisted of works by Jacobus Gallus/Lance Phillip, Béla Bartók, Peteris Vasks/Keith Moss, as well as Johann Sebastian Bach.
Ictus an ideal platform
The Ictus International Music Competition is an online music competition for wind bands, orchestras and solo trumpet. It has been described by David Bilger of the Philadelphia Orchestra as “democratising music competitions”. Ictus was founded to make international music competitions more accessible though eliminating prohibitive travel costs, conference fees and visa issues. This was made possible through having the application and adjudication take place online only.
You can listen to OMSC Ictus submissions here:
Duo Seraphim Jabobus Gallus/Lance Phillip
Romanian Folk Dances/ Román népi táncok Béla Bartók
Kekatu Dziesma (Carnival Song) Peteris Vasks/Keith Moss
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004